VIRAX BIOLABS GROUP LTD (VRAX) Stock Cash Flow
NASDAQ:VRAX - Nasdaq - KYG9495L1251 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -6.58M | -6.74M | -5.46M | -1.75M | -670.00K | |||
| Depreciation Amortization | 243.57K | 103.10K | N/A | N/A | N/A | |||
| Change In Working Capital | 170.44K | -1.12M | -182.33K | 640.00K | 60.00K | |||
| Interest Paid | 1.78K | 6.10K | 15.47K | N/A | N/A | |||
| Taxes Paid | N/A | 0.00 | 0.00 | N/A | N/A | |||
| Other non cash items | 1.60M | 1.51M | 1.46M | 300.00K | 20.00K | |||
| OPERATING CASH FLOW | -4.57M | -6.25M | -4.18M | -810.00K | -590.00K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -704.27K | -1.16M | -178.40K | N/A | N/A | |||
| INVESTING CASH FLOW | -704.27K | -1.16M | -178.40K | N/A | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -247.88K | -206.27K | 146.25K | 100.00K | N/A | |||
| Stock Issued/Repurchased | 7.79M | 1.87M | 13.65M | 520.00K | 400.00K | |||
| Other Financing Activity | -85.50K | -18.30K | -111.65K | 190.00K | 180.00K | |||
| FINANCING CASH FLOW | 7.45M | 1.65M | 13.69M | 810.00K | 590.00K | |||
| CHANGE IN CASH | 2.18M | -5.76M | 9.33M | 0.00 | 0.00 | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -4.57M | -6.25M | -4.18M | -810.00K | -590.00K | |||
| Capital Expenditure | -704.27K | -1.16M | -178.40K | N/A | N/A | |||
| FREE CASH FLOW | -5.28M | -7.41M | -4.36M | -810.00K | -590.00K | |||
All data in USD